Grantham, Mayo, Van Otterloo & Co (GMO)
CHNG

Grantham, Mayo, Van Otterloo & Co (GMO)’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,362,652
Closed -$37.5M – 801
2022
Q3 		$37.5M Sell
1,362,652
-1,372,891
-50% -$34M 0.22% 83
2022
Q2 		$63.1M Sell
2,735,543
-704,462
-20% -$16.5M 0.34% 57
2022
Q1 		$75M Sell
3,440,005
-729,000
-17% -$15.1M 0.36% 48
2021
Q4 		$89.1M Sell
4,169,005
-1,141,078
-21% -$23.9M 0.43% 42
2021
Q3 		$111M Buy
5,310,083
+1,218,638
+30% +$26.6M 0.55% 40
2021
Q2 		$94.3M Buy
4,091,445
+877,089
+27% +$20.2M 0.47% 46
2021
Q1 		$71M Buy
+3,214,356
New +$74.4M 0.39% 53

Other funds holding CHNG

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CHNG Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 1,362,652 shares — an estimated $37.5M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CHNG in Q1 2021 and held it in 7 quarters. The position peaked at $111M in Q3 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,362,652 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $37.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Change Healthcare Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Change Healthcare Inc. Common Stock position peaked at $111M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.